ArticleJournal of medical case reports2025
A fast and easy-to-perform noninvasive Muller's muscle sublimation technique using plasma technology for treatment of mild-to-moderate ptosis: a case report.
Article in Journal of medical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCurrently, most surgeons favor Muller's muscle conjunctival resection as a treatment for mild-to-moderate ptosis, as this method is associated with fewer post-surgical complications. CASE PRESENTATION: This case series of six Iranian women aged between 15 and 65 (mean 43) years with mild-to-moderate ptosis treated at Negah Eye Hospital used a plasma scalpel (PLEXR™) for conjunctivo-Muller sublimation. A 1-4 area management strategy was applied, and margin reflex distance 1 measurements showed improvement from 1.58 mm pre-treatment to 3.66 mm after 6 months.
conclusionSeemingly, applying plasma technology to treat mild-to-moderate ptosis via conjunctivo-Muller muscle sublimation might be a promising alternative to more invasive surgical methods.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.